{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:13:52Z","timestamp":1789992832505,"version":"4.0.1"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.addr.2025.115575","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T08:07:52Z","timestamp":1743754072000},"page":"115575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Intranasal and inhaled delivery systems for targeting circadian dysfunction in neurodegenerative disorders, perspective and future outlook"],"prefix":"10.1016","volume":"220","author":[{"given":"Rhearne","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew N.","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla M.","family":"Hoyos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Xin","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Traini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5423","key":"10.1016\/j.addr.2025.115575_b0005","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1126\/science.284.5423.2177","article-title":"Stability, precision, and near-24-hour period of the human circadian pacemaker","volume":"284","author":"Czeisler","year":"1999","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.addr.2025.115575_b0010","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13548","article-title":"Mammalian circadian systems: Organization and modern life challenges","volume":"231","author":"Finger","year":"2021","journal-title":"Acta Physiol."},{"issue":"1","key":"10.1016\/j.addr.2025.115575_b0015","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/ejn.14255","article-title":"Circadian disruption: What do we actually mean?","volume":"51","author":"Vetter","year":"2020","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.addr.2025.115575_b0020","unstructured":"Diagnostic and statistical manual of mental disorders: DSM-5\u2122, 5th ed. Arlington, VA, US: American Psychiatric Publishing, Inc.; 2013."},{"issue":"3","key":"10.1016\/j.addr.2025.115575_b0025","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1532-5415.2010.02733.x","article-title":"Frequency and correlates of caregiver\u2010reported sleep disturbances in a sample of persons with early dementia","volume":"58","author":"Rongve","year":"2010","journal-title":"J. Am. Geriatr. Soc."},{"issue":"2","key":"10.1016\/j.addr.2025.115575_b0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/mdc3.13122","article-title":"Prevalence of non\u2010motor symptoms and non\u2010motor fluctuations in Parkinson's disease using the MDS\u2010NMS","volume":"8","author":"Rodriguez-Blazquez","year":"2021","journal-title":"Movement Disorders Clinical Practice."},{"issue":"11","key":"10.1016\/j.addr.2025.115575_b0035","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202200237","article-title":"Circadian rhythm changes in healthy aging and mild cognitive impairment","volume":"7","author":"Keihani","year":"2023","journal-title":"Advanced Biology."},{"key":"10.1016\/j.addr.2025.115575_b0040","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.sleep.2019.04.018","article-title":"Evening melatonin timing secretion in real life conditions in patients with Alzheimer disease of mild to moderate severity","volume":"63","author":"Manni","year":"2019","journal-title":"Sleep Med."},{"issue":"5","key":"10.1016\/j.addr.2025.115575_b0045","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1176\/appi.ajp.158.5.704","article-title":"Sundowning and circadian rhythms in Alzheimer\u2019s disease","volume":"158","author":"Volicer","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.addr.2025.115575_b0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41398-022-01897-y","article-title":"Sleep in Alzheimer\u2019s disease: a systematic review and meta-analysis of polysomnographic findings","volume":"12","author":"Zhang","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"4","key":"10.1016\/j.addr.2025.115575_b0055","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3233\/JAD-131217","article-title":"Circadian misalignment and sleep disruption in mild cognitive impairment","volume":"38","author":"Naismith","year":"2013","journal-title":"Journal of Alzheimer\u2019s Disease."},{"issue":"3","key":"10.1016\/j.addr.2025.115575_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-7568(20)30015-5","article-title":"Circadian disturbances in Alzheimer's disease progression: a prospective observational cohort study of community-based older adults","volume":"1","author":"Li","year":"2020","journal-title":"The Lancet Healthy Longevity."},{"issue":"6","key":"10.1016\/j.addr.2025.115575_b0065","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/brain\/awn049","article-title":"Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia","volume":"131","author":"Harper","year":"2008","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.addr.2025.115575_b0070","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/00912700022009422","article-title":"The absolute bioavailability of oral melatonin","volume":"40","author":"DeMuro","year":"2000","journal-title":"J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.addr.2025.115575_b0075","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1242\/dmm.030627","article-title":"Central and peripheral circadian clocks and their role in Alzheimer's disease","volume":"10","author":"Chauhan","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.addr.2025.115575_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2018.10.001","article-title":"Sleep and circadian rhythm disruption and stress intersect in Alzheimer's disease","volume":"10","author":"Phan","year":"2019","journal-title":"Neurobiol. Stress"},{"issue":"3","key":"10.1016\/j.addr.2025.115575_b0085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1474-4422(18)30461-7","article-title":"Association between circadian rhythms and neurodegenerative diseases","volume":"18","author":"Leng","year":"2019","journal-title":"The Lancet Neurology."},{"issue":"2","key":"10.1016\/j.addr.2025.115575_b0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrneurol.2013.269","article-title":"Sleep and Alzheimer disease pathology\u2014a bidirectional relationship","volume":"10","author":"Ju","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.addr.2025.115575_b0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.smrv.2014.03.007","article-title":"Sleep and Alzheimer's disease","volume":"19","author":"Peter-Derex","year":"2015","journal-title":"Sleep Med. Rev."},{"issue":"5","key":"10.1016\/j.addr.2025.115575_b0100","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0197-4580(95)00059-N","article-title":"Circadian locomotor activity and core-body temperature rhythms in Alzheimer's disease","volume":"16","author":"Satlin","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.addr.2025.115575_b0105","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3389\/fpsyt.2019.00778","article-title":"A systematic review of evidence for a role of rest-activity rhythms in dementia","volume":"10","author":"Smagula","year":"2019","journal-title":"Front. Psych."},{"issue":"1","key":"10.1016\/j.addr.2025.115575_b0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/WAD.0000000000000037","article-title":"The rest-activity rhythm and physical activity in early-onset dementia","volume":"29","author":"Hooghiemstra","year":"2015","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"5","key":"10.1016\/j.addr.2025.115575_b0115","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamaneurol.2017.4719","article-title":"Circadian rest-activity pattern changes in aging and preclinical Alzheimer disease","volume":"75","author":"Musiek","year":"2018","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.addr.2025.115575_b0120","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jamaneurol.2013.6239","article-title":"Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease","volume":"71","author":"Videnovic","year":"2014","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.addr.2025.115575_b0125","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.sleep.2013.10.016","article-title":"Disturbances in melatonin secretion and circadian sleep\u2013wake regulation in Parkinson disease","volume":"15","author":"Bolitho","year":"2014","journal-title":"Sleep Med."},{"issue":"8","key":"10.1016\/j.addr.2025.115575_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072661","article-title":"The relationship between thermoregulation and REM sleep behaviour disorder in Parkinson\u2019s disease","volume":"8","author":"Zhong","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.addr.2025.115575_b0135","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.56.8.874","article-title":"Diurnal effects of motor activity and fatigue in Parkinson's disease","volume":"56","author":"Van Hilten","year":"1993","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"11","key":"10.1016\/j.addr.2025.115575_b0140","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/jnnp.54.11.976","article-title":"A new approach in the assessment of motor activity in Parkinson's disease","volume":"54","author":"Van Hilten","year":"1991","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.addr.2025.115575_b0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00002826-200001000-00006","article-title":"Diurnal motor variations to repeated doses of levodopa in Parkinson's disease","volume":"23","author":"Bonuccelli","year":"2000","journal-title":"Clin. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.addr.2025.115575_b0150","first-page":"219","article-title":"Diurnal worsening in Parkinson patients treated with levodopa","volume":"61","author":"Piccini","year":"1991","journal-title":"Riv. Neurol."},{"issue":"12","key":"10.1016\/j.addr.2025.115575_b0155","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0895-4356(00)00254-7","article-title":"Benzodiazepines with different half-life and falling in a hospitalized population: the GIFA study","volume":"53","author":"Passaro","year":"2000","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.addr.2025.115575_b0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00002512-200825010-00007","article-title":"Benzodiazepines and injurious falls in community dwelling elders","volume":"25","author":"Pariente","year":"2008","journal-title":"Drugs Aging"},{"key":"10.1016\/j.addr.2025.115575_b0165","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.drugpo.2015.08.005","article-title":"Prescription monitoring programs and emergency department visits involving benzodiazepine misuse: early evidence from 11 United States metropolitan areas","volume":"28","author":"Bachhuber","year":"2016","journal-title":"Int. J. Drug Policy"},{"issue":"6","key":"10.1016\/j.addr.2025.115575_b0170","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","article-title":"Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications","volume":"56","author":"Labiris","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.addr.2025.115575_b0175","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/00912709922008281","article-title":"Absolute oral versus inhaled bioavailability: significance for inhaled drugs with special reference to inhaled glucocorticoids","volume":"39","author":"Rohatagi","year":"1999","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.addr.2025.115575_b0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/jam.1994.7.49","article-title":"Drug delivery via the respiratory tract","volume":"7","author":"Byron","year":"1994","journal-title":"J. Aerosol Med."},{"issue":"1","key":"10.1016\/j.addr.2025.115575_b0185","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: structure, regulation and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.addr.2025.115575_b0190","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/pharmaceutics12020138","article-title":"Nose-to-brain delivery","volume":"12","author":"Giunchedi","year":"2020","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.addr.2025.115575_b0195","article-title":"In vitro evaluation of nasal aerosol depositions: an insight for direct nose to brain drug delivery","volume":"13(7","author":"Maaz","year":"2021","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.addr.2025.115575_b0200","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"195","author":"Crowe","year":"2018","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.addr.2025.115575_b0205","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14051073","article-title":"Different methods and formulations of drugs and vaccines for nasal administration","volume":"14","author":"Tai","year":"2022","journal-title":"Pharmaceutics."},{"issue":"1","key":"10.1016\/j.addr.2025.115575_b0210","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/lio2.135","article-title":"Olfactory epithelium: cells, clinical disorders, and insights from an adult stem cell niche","volume":"3","author":"Choi","year":"2018","journal-title":"Laryngoscope Investigative Otolaryngology."},{"issue":"7","key":"10.1016\/j.addr.2025.115575_b0215","article-title":"Non-invasive strategies for nose-to-brain drug delivery","volume":"10","author":"Trevino","year":"2020","journal-title":"J. Clin. Trials"},{"issue":"3","key":"10.1016\/j.addr.2025.115575_b0220","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1208\/s12248-015-9724-x","article-title":"Emerging insights for translational pharmacokinetic and pharmacokinetic-pharmacodynamic studies: towards prediction of nose-to-brain transport in humans","volume":"17","author":"Ruigrok","year":"2015","journal-title":"AAPS J."},{"issue":"4","key":"10.1016\/j.addr.2025.115575_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043390","article-title":"Biomaterials-enhanced intranasal delivery of drugs as a direct route for brain targeting","volume":"24","author":"Marcello","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.addr.2025.115575_b0230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40005-022-00589-5","article-title":"Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors","volume":"53","author":"Jeong","year":"2023","journal-title":"J. Pharm. Investig."},{"issue":"4","key":"10.1016\/j.addr.2025.115575_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16040481","article-title":"Nasal delivery to the brain: harnessing nanoparticles for effective drug transport","volume":"16","author":"Gandhi","year":"2024","journal-title":"Pharmaceutics."},{"issue":"8","key":"10.1016\/j.addr.2025.115575_b0240","first-page":"2088","article-title":"Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting","volume":"46","author":"Selvaraj","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"8","key":"10.1016\/j.addr.2025.115575_b0245","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/chemse\/bjy049","article-title":"Olfactory and trigeminal systems interact in the periphery","volume":"43","author":"Tremblay","year":"2018","journal-title":"Chem. Senses"},{"issue":"1","key":"10.1016\/j.addr.2025.115575_b0250","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1038\/s41598-019-39191-5","article-title":"Distribution of insulin in trigeminal nerve and brain after intranasal administration","volume":"9","author":"Lochhead","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.addr.2025.115575_b0255","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1021\/mp100029t","article-title":"Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures","volume":"7","author":"Johnson","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2025.115575_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebr.2022.100581","article-title":"The nose has it: opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters","volume":"21","author":"Chung","year":"2023","journal-title":"Epilepsy & Behavior Reports."},{"issue":"4","key":"10.1016\/j.addr.2025.115575_b0265","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin Microbiol Rev."},{"issue":"4","key":"10.1016\/j.addr.2025.115575_b0270","article-title":"Drug permeability: from the blood-brain barrier to the peripheral nerve barriers","volume":"6","author":"Sun","year":"2023","journal-title":"Adv Ther (weinh)"},{"key":"10.1016\/j.addr.2025.115575_b0275","unstructured":"Huang Q, Chen X, Yu S, Gong G, Shu H. Research progress in brain-targeted nasal drug delivery. Frontiers in aging neuroscience. ."},{"issue":"1","key":"10.1016\/j.addr.2025.115575_b0280","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41598-017-18561-x","article-title":"Enhanced nasal drug delivery efficiency by increasing mechanical loading using hypergravity","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"issue":"1\u20132","key":"10.1016\/j.addr.2025.115575_b0285","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijpharm.2010.06.008","article-title":"Drug release from hydroethanolic gels. effect of drug's lipophilicity (log P), polymer\u2013drug interactions and solvent lipophilicity","volume":"396","author":"Sawant","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2025.115575_b0290","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pmip.2019.01.002","article-title":"Options when anti-depressants cannot be used in conventional ways. clinical case and review of literature","volume":"15","author":"Das","year":"2019","journal-title":"Personalized Medicine Psychiatry."},{"issue":"3","key":"10.1016\/j.addr.2025.115575_b0295","doi-asserted-by":"crossref","first-page":"288","DOI":"10.18433\/J3NC79","article-title":"Intranasal drug delivery: how, why and what for?","volume":"12","author":"Pires","year":"2009","journal-title":"Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques."},{"key":"10.1016\/j.addr.2025.115575_b0300","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","article-title":"Progress in brain targeting drug delivery system by nasal route","volume":"268","author":"Khan","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2025.115575_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.hsr.2022.100038","article-title":"Potential of particle size less than 15 nm via olfactory region for direct brain delivery via intranasal route","volume":"4","author":"Handa","year":"2022","journal-title":"Health Sciences Review."},{"issue":"4","key":"10.1016\/j.addr.2025.115575_b0355","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1513\/pats.200409-046TA","article-title":"Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery","volume":"1","author":"Heyder","year":"2004","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"11","key":"10.1016\/j.addr.2025.115575_b0365","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1289\/ehp.8006","article-title":"Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells","volume":"113","author":"Geiser","year":"2005","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.addr.2025.115575_b0375","article-title":"Characteristics of compounds that cross the blood-brain barrier","volume":"9","author":"Banks","year":"2009","journal-title":"BMC Neurol."},{"issue":"8","key":"10.1016\/j.addr.2025.115575_b0315","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3109\/08958378.2015.1066904","article-title":"Olfactory deposition of inhaled nanoparticles in humans","volume":"27","author":"Garcia","year":"2015","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.addr.2025.115575_b0320","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejpb.2023.06.015","article-title":"Engineered dry powders for the nose-to-brain delivery of transforming growth factor-beta","volume":"189","author":"Wong","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"7","key":"10.1016\/j.addr.2025.115575_b0310","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071706","article-title":"Micro- and nanosized carriers for nose-to-brain drug delivery in neurodegenerative disorders","volume":"10","author":"Boyuklieva","year":"2022","journal-title":"Biomedicines."},{"issue":"10","key":"10.1016\/j.addr.2025.115575_bib661","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3109\/03639045.2016.1160110","article-title":"Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulation","volume":"42","author":"Pozzoli","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2025.115575_bib662","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jconrel.2022.09.047","article-title":"Involvement of trigeminal axons in nose-to-brain delivery of glucagon-like peptide-2 derivative","volume":"351","author":"Akita","year":"2022","journal-title":"J. Controlled Release"},{"issue":"5","key":"10.1016\/j.addr.2025.115575_b0340","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1517\/17425247.2011.565326","article-title":"Opportunities and challenges of the pulmonary route for vaccination","volume":"8","author":"Blank","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2025.115575_b0345","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2016.04.012","article-title":"The formulation of nanomedicines for treating tuberculosis","volume":"102","author":"Costa","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5044","key":"10.1016\/j.addr.2025.115575_b0350","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/211090a0","article-title":"Deposition of inhaled particles in human lungs","volume":"211","author":"Davies","year":"1966","journal-title":"Nature"},{"key":"10.1016\/j.addr.2025.115575_b0360","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1208\/s12249-014-0092-0","article-title":"Mechanisms of pharmaceutical aerosol deposition in the respiratory tract","volume":"15","author":"Cheng","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.addr.2025.115575_b0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-019-1334-y","article-title":"Ethambutol-loaded solid lipid nanoparticles as dry powder inhalable formulation for tuberculosis therapy","volume":"20","author":"Nemati","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.addr.2025.115575_bib663","doi-asserted-by":"crossref","first-page":"101631","DOI":"10.1016\/j.apmt.2022.101631","article-title":"On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles","volume":"29","author":"Formica","year":"2022","journal-title":"Appl. Mater. Today"},{"issue":"3","key":"10.1016\/j.addr.2025.115575_b0385","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030629","article-title":"Evaluation of recent intranasal drug delivery systems to the central nervous system","volume":"14","author":"Crowe","year":"2022","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.addr.2025.115575_b0390","unstructured":"Rajput A, Pingale P, Dhapte-Pawar V. Nasal delivery of neurotherapeutics via nanocarriers: Facets, aspects, and prospects. Front Pharmacol.."},{"key":"10.1016\/j.addr.2025.115575_b0395","first-page":"55","article-title":"Macrophage based drug delivery: Key challenges and strategies","volume":"38","author":"Guo","year":"2024","journal-title":"Bioact. Mater."},{"issue":"9","key":"10.1016\/j.addr.2025.115575_b0400","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.3390\/molecules14093754","article-title":"Nasal delivery of high molecular weight drugs","volume":"14","author":"Ozsoy","year":"2009","journal-title":"Molecules"},{"issue":"23","key":"10.1016\/j.addr.2025.115575_b0405","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S1359-6446(02)02529-1","article-title":"Nasal drug delivery: new developments and strategies","volume":"7","author":"Illum","year":"2002","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.addr.2025.115575_b0410","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3390\/pharmaceutics14030629","article-title":"Evaluation of recent intranasal drug delivery systems to the central nervous system","volume":"14","author":"Crowe","year":"2022","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.addr.2025.115575_b0415","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejps.2016.11.011","article-title":"In vitro biopharmaceutical evaluation of ciprofloxacin\/metal cation complexes for pulmonary administration","volume":"97","author":"Brillault","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5 Pt 2","key":"10.1016\/j.addr.2025.115575_b0420","article-title":"Measurements of pulmonary epithelial permeability in vivo","volume":"127","author":"Effros","year":"1983","journal-title":"Am Rev Respir Dis."},{"key":"10.1016\/j.addr.2025.115575_b0425","doi-asserted-by":"crossref","unstructured":"Kahraman E, G\u00fcng\u00f6r S, \u00d6zsoy Y. Nasal delivery of high molecular weight drugs: recent trends and clinical evidence. Nasal drug delivery: formulations, developments, challenges, and solutions. 2023:253-77.","DOI":"10.1007\/978-3-031-23112-4_13"},{"key":"10.1016\/j.addr.2025.115575_b0430","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jddst.2016.05.003","article-title":"Formulation and device design to increase nose to brain drug delivery","volume":"35","author":"Warnken","year":"2016","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"1","key":"10.1016\/j.addr.2025.115575_b0435","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2273.1999.00223.x","article-title":"Nasal pH measurement: a reliable and repeatable parameter","volume":"24","author":"England","year":"1999","journal-title":"Clin. Otolaryngol. Allied Sci."},{"issue":"2","key":"10.1016\/j.addr.2025.115575_b0440","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5173(99)00442-1","article-title":"Determination of baseline human nasal pH and the effect of intranasally administered buffers","volume":"198","author":"Washington","year":"2000","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.addr.2025.115575_b0445","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/17425247.2020.1702643","article-title":"Physical stability of dry powder inhaler formulations","volume":"17","author":"Shetty","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"issue":"9","key":"10.1016\/j.addr.2025.115575_b0450","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1016\/j.xphs.2019.05.011","article-title":"Simultaneous particle size reduction and homogeneous mixing to produce combinational powder formulations for inhalation by the single-step co-jet milling","volume":"108","author":"Ling","year":"2019","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.addr.2025.115575_b0455","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1089\/jam.2005.18.304","article-title":"An in vivo and in vitro comparison of two powder inhalers following storage at hot\/humid conditions","volume":"18","author":"Borgstr\u00f6m","year":"2005","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.addr.2025.115575_b0460","article-title":"Pulmonary inhalation for disease treatment: basic research and clinical translations","author":"Wang","year":"2024","journal-title":"Mater. Today Bio"},{"issue":"3","key":"10.1016\/j.addr.2025.115575_b0465","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11030113","article-title":"Strategies to enhance drug absorption via nasal and pulmonary routes","volume":"11","author":"Ghadiri","year":"2019","journal-title":"Pharmaceutics."},{"issue":"18","key":"10.1016\/j.addr.2025.115575_b0470","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1359-6446(02)02452-2","article-title":"Permeability issues in nasal drug delivery","volume":"7","author":"Arora","year":"2002","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.addr.2025.115575_b0475","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/pharmaceutics11030113","article-title":"Strategies to enhance drug absorption via nasal and pulmonary routes","volume":"11","author":"Ghadiri","year":"2019","journal-title":"Pharmaceutics."},{"issue":"2\u20133","key":"10.1016\/j.addr.2025.115575_b0480","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0169-409X(98)00085-4","article-title":"P-Glycoprotein, a gatekeeper in the blood\u2013brain barrier","volume":"36","author":"Schinkel","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2025.115575_b0485","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00003088-200342010-00003","article-title":"Role of P-glycoprotein in pharmacokinetics: clinical implications","volume":"42","author":"Lin","year":"2003","journal-title":"Clin. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.addr.2025.115575_b0490","doi-asserted-by":"crossref","DOI":"10.18773\/austprescr.2014.050","article-title":"P-glycoprotein and its role in drug-drug interactions","volume":"37","author":"Finch","year":"2014","journal-title":"Aust. Prescr."},{"issue":"1","key":"10.1016\/j.addr.2025.115575_b0495","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s13346-012-0108-9","article-title":"Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review","volume":"3","author":"Djupesland","year":"2013","journal-title":"Drug Deliv Transl Res."},{"key":"10.1016\/j.addr.2025.115575_b0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123892","article-title":"Intranasal delivery of thin-film freeze-dried monoclonal antibodies using a powder nasal spray system","volume":"653","author":"Yu","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.addr.2025.115575_b0505","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.drudis.2022.04.012","article-title":"Engineered nasal dry powder for the encapsulation of bioactive compounds","volume":"27","author":"Baldelli","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.addr.2025.115575_b0510","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4187\/respcare.11139","article-title":"Bronchodilator efficacy of high-flow nasal cannula in COPD: vibrating mesh nebulizer versus jet nebulizer","volume":"69","author":"Arunsurat","year":"2024","journal-title":"Respir Care."},{"key":"10.1016\/j.addr.2025.115575_b0515","doi-asserted-by":"crossref","unstructured":"Suggett J, Kushnarev V, Sadafi H. Dry Powder Inhalers (DPIs) vs Metered Dose Inhaler (MDI) with valved spacer: Using Functional Respiratory Imaging (FRI) to assess modelled lung deposition in a COPD patient. European Respiratory Journal.60(suppl 66):708.","DOI":"10.1183\/13993003.congress-2022.708"},{"issue":"11","key":"10.1016\/j.addr.2025.115575_b0520","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1007\/s11095-022-03286-y","article-title":"Nanotechnology-assisted metered-dose inhalers (MDIs) for high-performance pulmonary drug delivery applications","volume":"39","author":"Kumar","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2025.115575_b0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114530","article-title":"Formulation strategies, preparation methods, and devices for pulmonary delivery of biologics","volume":"204","author":"Berkenfeld","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.addr.2025.115575_b0530","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/jam.2006.19.67","article-title":"Regimen and device compliance: key factors in determining therapeutic outcomes","volume":"19","author":"Everard","year":"2006","journal-title":"J Aerosol Med."},{"key":"10.1016\/j.addr.2025.115575_b0535","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/CIA.S361519","article-title":"Current insights into the risks of using melatonin as a treatment for sleep disorders in older adults","author":"Tuft","year":"2023","journal-title":"Clin. Interv. Aging"},{"issue":"7","key":"10.1016\/j.addr.2025.115575_b0540","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.13011","article-title":"Melatonin receptors and sleep: moving beyond traditional views","volume":"76","author":"Comai","year":"2024","journal-title":"J. Pineal Res."},{"issue":"3","key":"10.1016\/j.addr.2025.115575_b0545","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jsmc.2022.06.007","article-title":"Drugs used in circadian sleep-wake rhythm disturbances","volume":"17","author":"Burgess","year":"2022","journal-title":"Sleep Med. Clin."},{"issue":"2","key":"10.1016\/j.addr.2025.115575_b0550","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3390\/antiox12020396","article-title":"Neuroprotective effect of melatonin on Sleep disorders Associated with Parkinson\u2019s Disease","volume":"12","author":"Hu","year":"2023","journal-title":"Antioxidants."},{"key":"10.1016\/j.addr.2025.115575_b0555","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00228-015-1873-4","article-title":"Clinical pharmacokinetics of melatonin: a systematic review","volume":"71","author":"Harps\u00f8e","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.addr.2025.115575_b0560","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/1099-081X(200001)21:1<15::AID-BDD215>3.0.CO;2-H","article-title":"Bioavailability of melatonin in humans after day\u2010time administration of D7 melatonin","volume":"21","author":"Fourtillan","year":"2000","journal-title":"Biopharm. Drug Dispos."},{"issue":"6","key":"10.1016\/j.addr.2025.115575_b0565","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1046\/j.1365-2125.2003.01933.x","article-title":"Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity","volume":"56","author":"H\u00e4rtter","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.addr.2025.115575_b0570","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2125.1985.tb02679.x","article-title":"Plasma concentrations of melatonin in man following oral absorption of different preparations","volume":"19","author":"Aldhous","year":"1985","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.addr.2025.115575_b0575","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00228-005-0908-7","article-title":"Influence of cigarette smoking on melatonin levels in man","volume":"61","author":"Ursing","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.addr.2025.115575_b0580","first-page":"462","article-title":"Evaluation of an oral pulsatile delivery system for melatonin in humans","volume":"53","author":"Hoffmann","year":"1998","journal-title":"Pharmazie"},{"key":"10.1016\/j.addr.2025.115575_b0585","article-title":"Melatonin: a potential nighttime guardian against Alzheimer\u2019s","volume":"1\u201314","author":"Zhang","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.addr.2025.115575_b0590","first-page":"327","article-title":"Sleep induction by intranasal application of melatonin. Melatonin: current status and perspectives","author":"Vollrath","year":"1981","journal-title":"Elsevier"},{"issue":"04","key":"10.1016\/j.addr.2025.115575_b0595","first-page":"169","article-title":"Pharmacokinetics of alternative administration routes of melatonin: a systematic review","volume":"66","author":"Zetner","year":"2016","journal-title":"Drug Research."},{"issue":"5","key":"10.1016\/j.addr.2025.115575_b0600","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1365-2125.2002.16133.x","article-title":"Population pharmacokinetics of intranasally administered low dose melatonin","volume":"53","author":"Helfrich","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.addr.2025.115575_b0605","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1212\/01.WNL.0000067993.60735.77","article-title":"Direct access of drugs to the human brain after intranasal drug administration?","volume":"60","author":"Merkus","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.addr.2025.115575_b0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(99)00019-8","article-title":"Intranasal absorption of melatonin in vivo bioavailability study","volume":"182","author":"Bechgaard","year":"1999","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.addr.2025.115575_b0615","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2003.11.028","article-title":"Intranasal administration of melatonin starch microspheres","volume":"272","author":"Mao","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2025.115575_b0620","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1023\/B:PHAM.0000026431.55383.69","article-title":"Uptake of melatonin into the cerebrospinal fluid after nasal and intravenous delivery: studies in rats and comparison with a human study","volume":"21","author":"Van Den Berg","year":"2004","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.addr.2025.115575_b0625","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4155\/tde-2017-0005","article-title":"Intranasal melatonin nanoniosomes: pharmacokinetic, pharmacodynamics and toxicity studies","volume":"8","author":"Priprem","year":"2017","journal-title":"Ther. Deliv."},{"issue":"2","key":"10.1016\/j.addr.2025.115575_b0630","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/biom13020232","article-title":"Multi-targeting intranasal nanoformulation as a therapeutic for Alzheimer\u2019s disease","volume":"13","author":"Fihurka","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.addr.2025.115575_b0635","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41419-019-1556-7","article-title":"Melatonin as a master regulator of cell death and inflammation: molecular mechanisms and clinical implications for newborn care","volume":"10","author":"Tarocco","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.addr.2025.115575_b0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2024.114601","article-title":"Simulated pharmacokinetics of inhaled caffeine and melatonin from existing products indicate the lack of dosimetric considerations","volume":"187","author":"Kolli","year":"2024","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.addr.2025.115575_b0650","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2105\/AJPH.2018.304804","article-title":"E-cigarettes are being marketed as \u201cvitamin delivery\u201d devices","author":"Bas\u00e1\u00f1ez","year":"2019","journal-title":"American Public Health Association"},{"issue":"5","key":"10.1016\/j.addr.2025.115575_b0655","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.16194","article-title":"Use patterns, flavors, brands, and ingredients of nonnicotine e-cigarettes among adolescents, young adults, and adults in the United States","volume":"5","author":"Gaiha","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"7","key":"10.1016\/j.addr.2025.115575_b0660","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1208\/s12249-018-1170-5","article-title":"A simple and rapid method for deposition and measurement of drug transport across air interface respiratory epithelia","volume":"19","author":"Haghi","year":"2018","journal-title":"AAPS PharmSciTech"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X25000602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X25000602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T18:34:02Z","timestamp":1744914842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X25000602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":130,"alternative-id":["S0169409X25000602"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2025.115575","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal and inhaled delivery systems for targeting circadian dysfunction in neurodegenerative disorders, perspective and future outlook","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2025.115575","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115575"}}